Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.240
0.00 (0.00%)
At close: Mar 9, 2026, 4:00 PM EDT
1.280
+0.040 (3.23%)
After-hours: Mar 9, 2026, 4:45 PM EDT
Allarity Therapeutics Market Cap
Allarity Therapeutics has a market cap or net worth of $19.94 million as of March 9, 2026. Its market cap has increased by 378.47% in one year.
Market Cap
19.94M
Enterprise Value
4.52M
1-Year Change
378.47%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since December 21, 2021, Allarity Therapeutics's market cap has decreased from $79.38M to $19.94M, a decrease of -74.88%. That is a compound annual growth rate of -27.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 19.94M | 16.84% |
| Dec 31, 2025 | 17.07M | 229.00% |
| Dec 31, 2024 | 5.19M | 106.50% |
| Dec 29, 2023 | 2.51M | -40.12% |
| Dec 30, 2022 | 4.20M | -94.65% |
| Dec 31, 2021 | 78.43M | -1.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lixte Biotechnology Holdings | 21.26M |
| Polyrizon | 20.90M |
| Reviva Pharmaceuticals Holdings | 20.87M |
| NanoViricides | 20.72M |
| Lexaria Bioscience | 20.63M |
| Genenta Science | 20.15M |
| Intensity Therapeutics | 20.14M |
| VYNE Therapeutics | 19.83M |